Ikiru (1952) and Terminal Stomach Cancer

Kanji Watanabe has spent thirty years as a Tokyo bureaucrat, stamping forms and moving awkward files to the bottom of the pile. He goes to hospital about his stomach. He is told, kindly and at length, that it is a mild ulcer.

Spoilers throughout. Watanabe's last year is the whole film, so this page describes how it closes.

He does not believe it. In the waiting room a stranger has already described, almost word for word, the reassurance a doctor gives a patient with stomach cancer. Watanabe hears his own consultation played back to him before it happens. He works out that he has perhaps a year.

He tries to drink and spend his way out of the knowledge, and it does not work. Then he spends what is left forcing a small playground through the same bureaucracy he once embodied. He dies on a swing in the snow. The film's second half is his wake, where colleagues argue about whether he knew, and vow to work as he did, and then do not.

The concealment is not a plot device. It is an accurate picture of how medicine behaved almost everywhere in the 1950s.

The scale of it is easy to underestimate. In a survey of physicians published in 1961, 90% said they preferred not to tell a cancer patient the diagnosis. When researchers sent the same questionnaire out again in 1977, 97% of the doctors who replied said they preferred to tell. Novack and colleagues, reporting that result in JAMA in 1979, called it a complete reversal of attitude — and noted it had happened on the basis of clinical instinct rather than any study.

So Ikiru sits at the near end of a practice that has since been abandoned. What the film records precisely is the cost of it. Watanabe is not spared anything. He gets the same fear, plus isolation, plus the extra work of decoding his own doctors. He cannot ask questions, because officially there is nothing to ask about. He cannot tell his son, because he was never told himself.

That is the argument against comfortable silence, made better in one waiting-room scene than in most ethics papers.

Two things are different now, and one is not.

Different: in most countries a patient is told their diagnosis and prognosis directly, and can decide how much detail they want. Also different: nobody with advanced stomach cancer today should be left with no offer at all. Treatment aimed at symptoms — pain, nausea, appetite, swallowing — is available even when cure is not.

Not different: Watanabe's decline is far gentler than the disease usually allows. He stays upright and effective for months. Advanced gastric cancer more often brings early fullness, vomiting, pain and serious weight loss well before the last weeks. Kurosawa needs him working, so he works.

The reason Watanabe is not diagnosed until late is not the 1950s. It is the disease.

NCI is blunt about it: early on, stomach cancer usually causes no symptoms, and symptoms tend to begin after the cancer has spread. When early symptoms do appear, they are these:

• Indigestion and stomach discomfort.
• A bloated feeling after eating.
• Mild nausea.
• Loss of appetite.
• Heartburn.

Read that list again and notice that it describes a bad week for millions of people. There is nothing in it to alarm anyone, which is precisely the problem.

More advanced disease adds signs that are harder to dismiss: stomach pain, vomiting, blood in the stool, weight loss for no known reason, trouble swallowing, jaundice, and fluid building up in the abdomen.

The practical rule is about duration, not drama. Indigestion that keeps coming back for weeks despite the usual remedies deserves a doctor's assessment rather than another packet of antacids. That goes double alongside weight loss, difficulty swallowing, or stools that are black or bloody.

NCI states that in the United States there are no standard or routine screening tests to detect stomach cancer in people at average risk.

That is not an oversight. Screening a whole population only makes sense when a disease is common enough that the test finds far more real cancers than false alarms. Stomach cancer is common in some countries and uncommon here, so a national endoscopy programme would put large numbers of well people through a camera test to find very few tumors.

Some people are offered endoscopy anyway, on specialist advice. NCI lists who may benefit: older people with chronic gastric atrophy, meaning a thinned stomach lining, or pernicious anaemia; people who have had part of the stomach removed; people with a family history of stomach cancer; people with certain genetic syndromes; and people from countries where the disease is more common.

If any of those describes you, that is a conversation worth having by name rather than waiting to be invited.

Cancer Explained is free and ad-free. Nothing is sold on this page. No sponsor sits behind it.

If this page helped you understand something about Ikiru, or moved you to ask a question you had been avoiding, reader support is what keeps it free for the next reader. Support our work.

Ikiru is one of the great films about how to spend a life, and it is not a guide to gastric cancer. What survives the translation is smaller and more useful than the playground: Watanabe felt something in his stomach for a long time before he did anything about it. Ikiru cannot tell you what to watch for, but screening and possible warning signs can.

This page discusses Ikiru for education. It is not medical advice, and nothing here is a judgement of anyone's real medical care. Spotted an error? Please email corrections@cancerexplained.org.